UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 558

Sortiert nach

001 Neurological manifestations of coronavirus disease 2019: a comprehensive review

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A1-A1

2021

Volltextzugriff (PDF)

1091 B1+ non-uniformity in 3 T CMR: patient study

Journal of cardiovascular magnetic resonance, 2008-10, Vol.10 (Suppl 1), p.A216-A216, Article A216

2008

Volltextzugriff (PDF)

1233 CRITICAL APPRAISAL OF MACHINE LEARNING PROGNOSTIC MODELS FOR ACUTE PANCREATITIS: A SYSTEMATIC REVIEW

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-286-S-286

2024

Volltextzugriff (PDF)

Abnormal Rod Dark Adaptation in Autosomal Dominant Retinitis Pigmentosa With Proline-23-Histidine Rhodopsin Mutation

American journal of ophthalmology, 1992-02, Vol.113 (2), p.165-174

1992

Volltextzugriff (PDF)

Abstract 1302: Targeting hormone receptor-dependent cancers with potent, selective and orally-available small molecule inhibitors of eIF4E

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1302-1302

2019

Volltextzugriff (PDF)

Abstract 1734: Investigating the Interactions of the human Autophagy Factor and Vici Syndrome Protein EPG5

The Journal of biological chemistry, 2023, Vol.299 (3), p.104059, Article 104059

2023

Volltextzugriff (PDF)

Abstract 214: The Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Phase 3 Trial: Primary Results

Stroke (1970), 2014-02, Vol.45 (suppl_1)

2014

Volltextzugriff (PDF)

Abstract 2170: Dissecting the oncogenic function of a novel androgen receptor-dependent direct target, cell cycle-related kinase ( CCRK ), in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2170-2170

2011

Volltextzugriff (PDF)

Abstract 2698: eFT226, a potent and selective inhibitor of eIF4A, is efficacious in preclinical models of lymphoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2698-2698

2019

Volltextzugriff (PDF)

Abstract 3001: Aberrantly up-regulated synaptotagmin-like 2 (SYTL2) promotes tumorigenesis of ovarian cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3001-3001

2013

Volltextzugriff (PDF)

Abstract B133: eFT226, a first in class inhibitor of eIF4A1, targets FGFR1/2 and HER2 driven cancers

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.B133-B133

2019

Volltextzugriff (PDF)

Abstract B33: Targeting PI3K/mTOR signaling with potent, selective and orally-available small-molecule inhibitors of eIF4E

Molecular cancer research, 2020-10, Vol.18 (10_Supplement), p.B33-B33

2020

Volltextzugriff (PDF)

Abstract DDT02-05: eFT226: A selective and highly potent inhibitor of eukaryotic initiation factor 4A (eIF4A), a novel approach for the treatment of cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.DDT02-05-DDT02-05

2018

Volltextzugriff (PDF)

Abstract MP75: Recalibration and Additional Data Domains Leads to Modestly Improved Performance of Risk Calculators for Heart Failure Readmission

Circulation (New York, N.Y.), 2020-03, Vol.141 (Suppl_1)

2020

Volltextzugriff (PDF)

Abstract OT1-08-08: CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2- metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT1-08-08-OT1-08-08

2020

Volltextzugriff (PDF)

Abstract PD9-05: Stromal tumor-infiltrating lymphocytes identify early-stage triple-negative breast cancer patients with favorable outcomes at 10-year follow-up in the absence of systemic therapy: a pooled analysis of 1835 patients

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD9-05-PD9-05

2023

Volltextzugriff (PDF)

Abstract TP82: Factors Associated With Trainee Burden In Post-stroke Goals Of Care Meetings

Stroke (1970), 2023-02, Vol.54 (Suppl_1)

2023

Volltextzugriff (PDF)

Abstract WP239: Development and Validation of The California Stroke Subtype (CASS) Scale for Prehospital Identification of Intracerebral Hemorrhage

Stroke (1970), 2016-02, Vol.47 (suppl_1)

2016

Volltextzugriff (PDF)

Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?

Clinical infectious diseases, 2024-04, Vol.78 (Supplement_2), p.S83-S92

2024

Volltextzugriff (PDF)

Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II

Infection and Immunity, 1990-12, Vol.58 (12), p.3959-3965

1990

Volltextzugriff (PDF)

Additive Effects of Nicotine and High-Fat Diet on Hepatic Steatosis in Male Mice

Endocrinology (Philadelphia), 2012-12, Vol.153 (12), p.5809-5820

2012

Volltextzugriff (PDF)

Advanced Optical Methods for Brain Imaging

1st ed. 2019., 2018

Volltextzugriff (PDF)

Adverse jaw outcomes from immune checkpoint inhibitors for head and neck cancer? Case reports

Quintessence international (Berlin, Germany : 1985), 2024-03, Vol.55 (3), p.244

2024

Volltextzugriff (PDF)

AG-221 Offers a Survival Advantage In a Primary Human IDH2 Mutant AML Xenograft Model

Blood, 2013-11, Vol.122 (21), p.240-240

2013

Volltextzugriff (PDF)

Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-[kappa]B essential modulator deficiency

Journal of allergy and clinical immunology, 2008-12, Vol.122 (6), p.1113-1118.e1

2008

Volltextzugriff (PDF)

1 – 25 von 558

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(504)
Mit Volltextzugriff
(493)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(355)
Life Sciences & Biomedicine
(251)
Humans
(152)
Female
(86)
Male
(77)
Animals
(76)
Physical Sciences
(67)
Technology
(61)
Middle Aged
(49)
Adult
(42)
Aged
(42)
Mice
(41)
Biological And Medical Sciences
(40)
Chemistry
(40)
Science & Technology - Other Topics
(40)
Neurosciences & Neurology
(36)
Surgery
(36)
Medical Sciences
(34)
Biochemistry & Molecular Biology
(30)
Engineering
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

001 Neurological manifestations of coronavirus disease 2019: a comprehensive review

1091 B1+ non-uniformity in 3 T CMR: patient study

1233 CRITICAL APPRAISAL OF MACHINE LEARNING PROGNOSTIC MODELS FOR ACUTE PANCREATITIS: A SYSTEMATIC REVIEW

Abnormal Rod Dark Adaptation in Autosomal Dominant Retinitis Pigmentosa With Proline-23-Histidine Rhodopsin Mutation

Abstract 1302: Targeting hormone receptor-dependent cancers with potent, selective and orally-available small molecule inhibitors of eIF4E

Abstract 1734: Investigating the Interactions of the human Autophagy Factor and Vici Syndrome Protein EPG5

Abstract 214: The Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Phase 3 Trial: Primary Results

Abstract 2170: Dissecting the oncogenic function of a novel androgen receptor-dependent direct target, cell cycle-related kinase ( CCRK ), in hepatocellular carcinoma

Abstract 2698: eFT226, a potent and selective inhibitor of eIF4A, is efficacious in preclinical models of lymphoma

Abstract 3001: Aberrantly up-regulated synaptotagmin-like 2 (SYTL2) promotes tumorigenesis of ovarian cancer cells

Abstract B133: eFT226, a first in class inhibitor of eIF4A1, targets FGFR1/2 and HER2 driven cancers

Abstract B33: Targeting PI3K/mTOR signaling with potent, selective and orally-available small-molecule inhibitors of eIF4E

Abstract DDT02-05: eFT226: A selective and highly potent inhibitor of eukaryotic initiation factor 4A (eIF4A), a novel approach for the treatment of cancer

Abstract MP75: Recalibration and Additional Data Domains Leads to Modestly Improved Performance of Risk Calculators for Heart Failure Readmission

Abstract OT1-08-08: CONTESSA TRIO: A multinational, multicenter, phase 2 study of tesetaxel plus 3 different PD-(L)1 inhibitors in patients with metastatic triple-negative breast cancer (TNBC) and tesetaxel monotherapy in elderly patients with HER2- metastatic breast cancer (MBC)

Abstract PD9-05: Stromal tumor-infiltrating lymphocytes identify early-stage triple-negative breast cancer patients with favorable outcomes at 10-year follow-up in the absence of systemic therapy: a pooled analysis of 1835 patients

Abstract TP82: Factors Associated With Trainee Burden In Post-stroke Goals Of Care Meetings

Abstract WP239: Development and Validation of The California Stroke Subtype (CASS) Scale for Prehospital Identification of Intracerebral Hemorrhage

Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?

Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II

Additive Effects of Nicotine and High-Fat Diet on Hepatic Steatosis in Male Mice

Advanced Optical Methods for Brain Imaging

Adverse jaw outcomes from immune checkpoint inhibitors for head and neck cancer? Case reports

AG-221 Offers a Survival Advantage In a Primary Human IDH2 Mutant AML Xenograft Model

Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-[kappa]B essential modulator deficiency

Suchergebnisse filtern